Biosimilars Market Report 2019-2026 -A Comprehensive Insights into Current Industry Trends, Trend Forecast and Growth Drivers

-

The latest market research report titled Biosimilars Market offers a detailed evaluation of the market situation within a specific geographic region. This Biosimilars Market study contains vital data on market shifts owing to social, economic, cultural and technological changes worldwide. Explaining market opportunities remains the key focus of the study. Industry experts analysing the business environment also take a closer look at the organizational alignment as well as the capital structure
According to the current analysis of Reports and Data, the global Biosimilars market was valued at USD 5.10 Billion in 2018 and is expected to reach USD 44.56 Billion by year 2026, at a CAGR of 30.8%. Biosimilar are alternatives to existing patented, and approved biologicss and possess similar medicinal properties as compared to the original biologics. The biosimilars vary a little from original biologics in terms of structure but must have similar safety and efficacy as compared to the originator biologics. Biosimilars development does not require Phase II clinical trial for approval and the focus is put on determination of ‘biosimilarity’ to the reference originator biologics. Thus it has much reduced clinical development timelines and reduced product costs as compared to use of original biologics.
The global market is driven by various of factors such as global prevalence of target disease prevalence across the globe, launch of biosimilars by various market players, favorable investments scenario, and upcoming patent expiry.
Request for PDF Sample at: https://www.reportsanddata.com/sample-enquiry-form/1177
Further key findings from the report suggest
  • Biosimilars market is growing at a CAGR of 2% in Asia Pacific followed by North America and Europe, with 21.0% and 31.4% CAGR, respectively. High chronic disease prevalence across the globe is the key factor to accelerate the market growth during forecast period across all regions.
  • As of 2018, Recombinant Non-glycosylated Proteins is the dominating Biosimilars which holds over 60% of the global market. European regional market is the chief revenue generating source for this product segment, followed by North America and Asia-Pacific regions.
  • Recombinant Glycosylated Proteins is expected to be the fastest growing market segment during forecast period 2019-2026 with a CAGR of 33.4%. However, regulatory obstacles and manufacturing complexity are major challenge for the market growth of this market segment.
  • Recombinant Peptides segment was estimated to account for USD 501.00 million in 2018 and is expected to grow reach USD 4.38 Billion by year 2026.
  • Asia Pacific is expected to account for the 32.8% of the global Biosimilars market. Developing nations such China, and India are likely to witness high growth.
  • Some regions such as U.S. and Latin America are facing slow adoption of biosimilars due to stringent regulatory framework..
  • Key participants include Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Mylan, Pfizer, Samsung Biologics, Sandoz, Stada Arzneimittel, and Teva Pahrmaceutical .
Read more at: https://www.reportsanddata.com/report-detail/global-biosimilars-market
For the purpose of this report, Reports and Data has segmented the Biosimilars market on the basis of type, disease type, and region:
Type (Revenue, USD Million; 2016–2026)
  • Recombinant Non-glycosylated Proteins
    • Insulin
    • Recombinant Human Growth Hormone
    • Granulocyte Colony-stimulating Factor
      • Filgrastim
      • Pegfilgrastim
    • Interferons
      • Interferon-Beta
      • Interferon-Alpha
    • Recombinant Glycosylated Proteins
      • Erythropoietin
      • Monoclonal Antibodies
        • Adalimumab
        • Bevacizumab
        • Infliximab
        • Rituximab
        • Trastuzumab
        • Other Monoclonal Antibodies
      • Follitropin
      • Etanercept
    • Recombinant Peptides
      • Glucagon
      • Calcitonin
Ask for Discount at: https://www.reportsanddata.com/discount-enquiry-form/1177
Disease Type (Revenue, USD Million; 2016–2026)
  • Oncology
  • Blood Disorders
  • Chronic Diseases
  • Autoimmune Diseases
  • Growth Hormone Deficiency
  • Infectious Diseases
  • Other Diseases
Regional Outlook (Revenue in USD Million; 2016–2026)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America
    • Brazil
Browse More Reports of Pharmaceutical Category At: https://www.reportsanddata.com/report/category/pharmaceutical

Comments

Post a Comment

Popular posts from this blog

Medical Waste Management Market: Industry Growth, Competitive Analysis, Future Prospects and Forecast 2026

-
Rise in elderly population, development of advanced manufacturing techniques for medical & drugs equipment, increasing initiative by government towards developing the healthcare infrastructure across the world, favorable research funding scenario, increase in health care expenditure, and rise in awareness regarding medical waste are key factors contributing to high CAGR of Medical Waste Management during forecast period. Market Size – USD 11.77 Billion in 2018, Market Growth - CAGR of 5.3%, Market Trends – Outsourcing of medical waste management services and growing health care industry According to the current analysis of Reports and Data, the global  Medical waste management market  was valued at USD 11.77 billion in 2018 and is expected to reach USD 17.89 billion by the year 2026, at a CAGR of 5.3%. The study talks about the growing population across the globe, which in turn increases the number of patients, resulting in the rising volume of medical waste. To id...
Read more

Automotive Repair & Maintenance service Market Size, Share & Trends | Industry Report, 2018-2026

-
Increasing safety requirements for passengers, especially in growing economies and increase in technological advancements are the major factors influencing market growth. Market Size – USD 516.14 billion in 2018, Market Growth - CAGR of 5.6%, Market Trends –Rise in demand for electric vehicles. The global  Automotive Repair & Maintenance Service Market  is estimated to reach USD 810.30 Billion by 2026, according to a new report by Reports and Data. This can be mainly associated with the growing need for passenger’s safety. Increase in awareness related to vehicle maintenance and safety is expected to drive the market. Increased road safety awareness among the general population, the average maintenance and repair expenses by an individual are anticipated to drive the market. Moreover, an increase in sales of used cars in many regions, especially in emerging economies; technological advancements pertaining to vehicle safety, are also fuelling market growth. Furthermo...
Read more

Tire Material Market: Potential Effect on Upcoming Future Growth, Competitive Analysis and Forecast 2026

-
The global  tire material market  is forecast to reach USD 110.76 Billion by 2026, according to a new report by Reports and Data. The market is rising rapidly as the sales of passenger cars are propelling mostly in the developing regions due to an increase in disposable earning. The overall vehicle sales globally have also increased substantially because of the technological advancements in the automotive industry. The rise in demand for green tires in Europe has helped the tire material market grow apace. The Asia Pacific region is forecasted to generate the highest revenue of USD 40.76 Billion in the year 2026, owing to its record increasing sales of passenger vehicles and two-wheelers segment in the developing economies such as India and Thailand. To identify the key trends in the industry, click on the link below:  https://www.reportsanddata.com/report-detail/tire-material-market
Read more